Published in Medical Letter on the CDC and FDA, March 29th, 2009
"The approval of biogenerics legislation would provide Americans access to more affordable biologic drugs and save the healthcare system billions of dollars," said Christopher Begley, chairman and chief executive officer, Hospira. "We look forward to working with Congress and the Obama administration to pass biogenerics legislation in 2009."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA